⌘K

Login Start Free

Home/Filings/4/0001358403-17-000089

4//SEC Filing

BELLICUM PHARMACEUTICALS, INC 4

Accession 0001358403-17-000089

CIK 0001358403operating

View on SEC.gov Company Profile

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 4:34 PM ET

Size

5.4 KB

Accession

0001358403-17-000089

Insider Transaction Report

Form 4

Period: 2017-06-14

BELLICUM PHARMACEUTICALS, INCBLCM

Director

Transactions

Award
Stock Option (right to buy)
2017-06-14+10,000→ 10,000 total
Exercise: $10.34Exp: 2027-06-13→ Common Stock (10,000 underlying)

Footnotes (1)

[F1]The shares subject to the option vest and become exercisable in equal monthly installments until the Issuer's 2018 Annual Meeting of stockholders.

Documents

1 file

4
wf-form4_149755882517307.xmlPrimary
FORM 4

Issuer

BELLICUM PHARMACEUTICALS, INC

CIK 0001358403

Entity typeoperating

Related Parties

1

filerCIK 0001358403

Filing Metadata

Form type: 4
Filed: Jun 14, 8:00 PM ET
Accepted: Jun 15, 4:34 PM ET
Size: 5.4 KB

View on SEC.gov